| Literature DB >> 34968309 |
Manish S Patel1, Lauren C Hogshire1, Helaine Noveck1, Michael B Steinberg1, Donald R Hoover2, Jane Rosenfeld1, Akanksha Arya3, Jeffrey L Carson1.
Abstract
The role of advanced practice providers has expanded in the hospital setting. However, little data exist examining the impact of these providers. Our purpose was to determine the effect of adding nurse practitioners in a complementary role on the quality and efficiency of care of hospitalized patients. A retrospective cohort study evaluated adult patients admitted by private physicians (without house staff or non-physician providers) to a general medical-surgical unit in an academic medical center. The admissions department allocated patients as beds became available and nurse practitioners were assigned to patients until their caseload was reached. Outcomes included length of hospital stay, in-hospital mortality, admission costs, 30-day readmissions, transfer to a more intensive care level, and discharge order time. Of the 382 patients included in this study, 263 were assigned to the nurse practitioner group. Hospital mortality was lower in the nurse practitioner group [OR 0.11 (95% CI 0.02-0.51)] as was transfer to more intensive care level [OR 0.39 (95% CI 0.20-0.75)]; however, the nurse practitioner group had longer length of stay (geometric mean = 5.80 days for nurse practitioners, 3.63 days for no nurse practitioners; p < 0.0001) and higher cost per patient (geometric mean = USD 6631 vs. USD 5121; p = 0.005). The results were unchanged when models were adjusted for potential confounders. Adding nurse practitioners can yield improved clinical outcomes (lower hospital mortality and fewer transfers to intensive care), but with a potential economic expense (longer hospital stays and higher costs).Entities:
Keywords: hospital; inpatient; nurse practitioner; outcomes; quality of care
Year: 2021 PMID: 34968309 PMCID: PMC8608079 DOI: 10.3390/nursrep11010003
Source DB: PubMed Journal: Nurs Rep ISSN: 2039-439X
Baseline Characteristics.
| Nurse Practitioner | Control Group | Overall | |||||
|---|---|---|---|---|---|---|---|
|
| 0.38 | ||||||
| Male | 150 | (57.0) | 62 | (52.1) | 212 | (55.5) | |
| Female | 113 | (43.0) | 57 | (47.9) | 170 | (44.5) | |
|
| 0.51 | ||||||
| Less than 65 | 72 | (27.4) | 41 | (34.5) | 113 | (29.6) | |
| 65 to 75 | 66 | (25.1) | 30 | (25.2) | 96 | (25.1) | |
| 76 to 84 | 60 | (22.8) | 22 | (18.5) | 82 | (21.5) | |
| 85 and older | 65 | (24.7) | 26 | (21.8) | 91 | (23.8) | |
|
| 0.28 | ||||||
| 0 points | 88 | (33.5) | 36 | (30.3) | 124 | (32.5) | |
| 1 point | 41 | (15.6) | 30 | (25.2) | 71 | (18.6) | |
| 2 points | 54 | (20.5) | 21 | (17.6) | 75 | (19.6) | |
| 3 points | 31 | (11.8) | 14 | (11.8) | 45 | (11.8) | |
| 4 or more points | 49 | (18.6) | 18 | (15.1) | 67 | (17.5) | |
|
| |||||||
| Infectious Disease | 12 | (4.6) | 6 | (5.0) | 18 | (4.7) | 0.80 |
| Neoplasm | 13 | (4.9) | 7 | (5.9) | 20 | (5.2) | 0.80 |
| Endocrine Disorder | 14 | (5.3) | 5 | (4.2) | 19 | (5.0) | 0.80 |
| Hematologic Disorder | 10 | (3.8) | 2 | (1.7) | 12 | (3.1) | 0.35 |
| Mental Disorder | 1 | (0.4) | 2 | (1.7) | 3 | (0.8) | 0.23 |
| Neurologic Disease | 7 | (2.7) | 3 | (2.5) | 10 | (2.6) | 1.00 |
| Cardiovascular Disease | 62 | (23.6) | 26 | (21.8) | 88 | (23.0) | 0.79 |
| Respiratory Disease | 45 | (17.1) | 25 | (21.0) | 70 | (18.3) | 0.39 |
| Gastrointestinal Disease | 37 | (14.1) | 13 | (10.9) | 50 | (13.1) | 0.51 |
| Genitourinary Disease | 22 | (8.4) | 9 | (7.6) | 31 | (8.1) | 1.00 |
| Skin and Subcutaneous Disease | 12 | (4.6) | 5 | (4.2) | 17 | (4.5) | 1.00 |
| Musculoskeletal and Connective Tissue Disease | 7 | (2.7) | 6 | (5.0) | 13 | (3.4) | 0.24 |
| Injury and Poisoning | 21 | (8.0) | 10 | (8.4) | 31 | (8.1) | 1.00 |
Outcome Measures of Dichotomous Variables.
| Outcome | Nurse Practitioner | Control | Unadjusted OR | Adjusted OR |
|---|---|---|---|---|
| In-hospital mortality | 2 (0.8) | 8 (6.7) | 0.11 (0.02–0.51) | 0.09 (0.02–0.44) |
| Transfer to more intensive care level | 19 (7.2) | 20 (16.8) | 0.39 (0.20–0.75) | N/A |
| 30-day readmission | 40 (15.2) | 16 (13.4) | 1.15 (0.62–2.16) | 1.13 (0.60–2.12) |
| Discharge order written by 11AM | 52 (20.3) | 25 (22.9) | 0.86 (0.50–1.47) | N/A |
OR, odds ratio; CI, confidence interval. * Stepwise modeling for potential confounders (age, gender, Charlson Co-Morbidity Index, admitting diagnosis): In-hospital death-retained Charlson Co-Morbidity Index in final model. Transfer to more intensive care—no potential confounders in final model. Readmission within 30 days resulted in a retained Charlson Co-Morbidity Index. Discharge order written by 11 a.m.—no potential confounders in final model.
Outcomes Measures of Continuous Variables.
| Outcome | Nurse Practitioner | Control | Ratio of GM (NP/Control) | |
|---|---|---|---|---|
| Unadjusted | Adjusted | |||
| Length of Stay (days) | 5.80 (5.29–6.36) | 3.63 (3.13–4.22) | 1.60 (1.35–1.89) | 1.58 (1.34–1.86) |
| Cost of Admission (USD) | 6631 (6023–7300) | 5121 (4372–5999) | 1.29 (1.08–1.55) | 1.28 (1.07–1.52) |
GM, geometric mean; CI, confidence interval; NP, nurse practitioner; USD, United States Dollar. * Stepwise modeling for potential confounders (age, gender, Charlson Co-Morbidity Index, admitting diagnosis): Both outcomes retained Charlson Co-Morbidity Index in final model.